| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $203.6M | +53.8% |
| Cost of Revenue | $119.3M | +48.0% |
| R&D Expense | $120.3M | +74.2% |
| SG&A Expense | $212.9M | +56.7% |
| Operating Income | -$234.8M | -53.7% |
| Interest Expense | $80K | -78.2% |
| Pre-tax Income | -$228.3M | -48.2% |
| Income Tax | -$10.4M | -439.4% |
| Net Income | -$217.9M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $378.7M | -18.7% |
| Short-term Investments | $126.3M | +949.4% |
| Accounts Receivable | $40.3M | +41.1% |
| Inventory | $39.3M | +23.6% |
| Current Assets | $596.5M | +9.1% |
| Total Assets | $961.4M | +36.9% |
| Current Liabilities | $90.7M | +43.8% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$124.4M | -10.8% |
| Capital Expenditures | $101.9M | +276.4% |
| Investing Cash Flow | -$232.9M | -249.2% |
| Financing Cash Flow | $270.5M | -17.8% |
| Free Cash Flow | -$226.2M | -62.4% |
| -43.2% |
| EPS (Basic) | -$4.04 | -28.3% |
| EPS (Diluted) | -$4.04 | -28.3% |
| Total Liabilities |
| $172.0M |
| +41.8% |
| Stockholders' Equity | $789.4M | +35.9% |